(2R,3S,4S,5S,6R)-2-(((2S,3S,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2R,3S,4S,5S,6R)-2-(((2S,3S,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
• 英文别名: 2-[4,5-dihydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
• 化学式: C₁₃H₂₄O₁₁
• 分子量: 356.32
• InChiKey: YUAFWDJFJCEDHL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.6
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  179
• 氢给体数：
  7
• 氢受体数：
  11

文献信息

• DENDRIMERS WITH A SACCHARIDE ENDING FOR ANTI-INFLAMMATORY PURPOSES
  申请人：Prandi Jacques

  公开号：US20130274210A1

  公开（公告）日：2013-10-17

  The present invention relates to dendrimers with a monosaccharide, oligosaccharide or polysaccharide terminal group, to their preparation method and their therapeutic uses, notably anti-inflammatory uses.

  本发明涉及具有单糖、寡糖或多糖末端基团的树状分子，其制备方法以及它们的治疗用途，特别是抗炎用途。
• TISSUE DEGENERATION PROTECTION
  申请人：Geuns Joannes

  公开号：US20100099640A1

  公开（公告）日：2010-04-22

  The present invention provides isolated or essentially pure diterpenoic tetrahydropyran, such as steviol-19-glucuronide, steviol, stevioside and rebaudioside processes for obtaining the same and methods for obtaining stable pharmaceutically acceptable salts of the same for use of such compounds or compositions in a treatment of cardiovascular disorders or vascular disease or for the manufacture of medicaments to treat a condition of a cardiovascular disorder or vascular disease.

  本发明提供了分离或基本纯的二萜四氢吡喃类化合物，例如甜菊糖苷-19-葡萄糖醛酸酯，甜菊糖，甜菊糖苷和葛根糖苷，以及获得它们的方法和获得这些化合物的稳定的药学上可接受的盐的方法，用于治疗心血管疾病或血管疾病或用于制造治疗心血管疾病或血管疾病症状的药物。
• Non-caloric sweeteners and methods for synthesizing
  申请人：Conagen Inc.

  公开号：US10442831B2

  公开（公告）日：2019-10-15

  Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebaudioside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside (Reb W).

  还公开了生产甜菊糖甙 M (Reb M)、甜菊糖甙 G (Reb G)、甜菊糖甙 KA (Reb KA)、甜菊糖甙 V (Reb V) 和甜菊糖甙 (Reb W) 的方法。
• Diterpene glycosides containing an ent-atisene core, compositions and methods
  申请人：The Coca-Cola Company

  公开号：US11447516B2

  公开（公告）日：2022-09-20

  Novel diterpene glycosides containing ent-atisene cores are provided herein. Compositions and consumables comprising the novel diterpene glycosides are also provided herein. Methods of enhancing the sweetness and/or flavor of consumables using the novel diterpene glycosides, methods of preparing compositions and consumables comprising the novel diterpene glycosides and methods of purifying the novel diterpene glycosides are also provided.

  本文提供了含有ent-atisene核心的新型二萜苷。本文还提供了包含新型二萜苷的组合物和消费品。还提供了使用新型二萜苷类提高消费品甜度和/或风味的方法、制备包含新型二萜苷类的组合物和消费品的方法以及纯化新型二萜苷类的方法。
• HYBRID GLYCOSYLATED PRODUCTS AND THEIR PRODUCTION AND USE
  申请人：Biotica Technology Limited

  公开号：EP1278881B1

  公开（公告）日：2009-12-30